"Designing Growth Strategies is in our DNA"

Treatment-Resistant Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Type (N-methyl-D-aspartate (NMDA), Antidepressants, Antipsychotics, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecasts, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102820

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Treatment-Resistant Depression, By Key Countries/Regions, 2022
    2. Overview of Current Advances in R&D for Antipsychotic Drugs
    3. Pipeline Analysis: Key Players
    4. Key Industry Developments, Mergers, Acquisitions, Etc.
    5. Impact of COVID-19 on Market
  5. Global Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. N-methyl-D-aspartate (NMDA)
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. N-methyl-D-aspartate (NMDA)
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. N-methyl-D-aspartate (NMDA)
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. N-methyl-D-aspartate (NMDA)
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. N-methyl-D-aspartate (NMDA)
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GlaxoSmithKline
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Janssen Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. H. Lundbeck
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sandoz International GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Par Pharmaceutical Companies Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Otsuka Holdings Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Treatment-Resistant Depression Treatment Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2: Global Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2022 & 2030

Figure 3: Global Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 4: Global Treatment-Resistant Depression Treatment Market Value (USD billion), by Region, 2022 & 2030

Figure 5: North America Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2022 & 2030

Figure 6: North America Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2022

Figure 7: North America Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 8: North America Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 9: North America Treatment-Resistant Depression Treatment Market Value (USD billion), By Country, 2022 & 2030

Figure 10: North America Treatment-Resistant Depression Treatment Market Value Share (%), By Country, 2022

Figure 11: Europe Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2022 & 2030

Figure 12: Europe Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2022

Figure 13: Europe Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 14: Europe Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 15: Europe Treatment-Resistant Depression Treatment Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 16: Europe Treatment-Resistant Depression Treatment Market Value Share (%), By Country/ Sub-region, 2022

Figure 17: Asia Pacific Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2022 & 2030

Figure 18: Asia Pacific Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2022

Figure 19: Asia Pacific Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 20: Asia Pacific Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 21: Asia Pacific Treatment-Resistant Depression Treatment Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 22: Asia Pacific Treatment-Resistant Depression Treatment Market Value Share (%), By Country/ Sub-region, 2022

Figure 23: Rest of the World Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2022 & 2030

Figure 24: Rest of the World Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2022

Figure 25: Rest of the World Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 26: Rest of the World Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 27: Global Treatment-Resistant Depression Treatment Market Share (%), By Company, 2022

Table 1: Global Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2019-2030

Table 2: Global Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 3: Global Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 4: North America Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2019-2030

Table 5: North America Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 6: North America Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 7: Europe Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2019-2030

Table 8: Europe Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 9: Europe Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 10: Asia Pacific Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2019-2030

Table 11: Asia Pacific Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 12: Asia Pacific Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 13: Rest of the World Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2019-2030

Table 14: Rest of the World Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Treatment-Resistant Depression Treatment Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 120
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase